Bortezomib analog

Compound 13 is a Bortezomib analog designed as a potent and selective inhibitor of the 20S proteasome's β5 subunit. It serves as a critical active control compound in proteasome research, facilitating mechanistic studies and comparative analyses in both in vitro biochemical assays and in vivo models of proteasome dysfunction.